Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Post-translational modification (PTM) refers to the covalent and generally enzymatic alteration of proteins following their biosynthesis (translation). PTMs are essential for regulating protein function, localization, stability, and interactions within the cell. They occur on specific amino acid side chains or at the N- or C-termini of proteins and can be reversible or irreversible. PTMs regulate key cellular processes such as enzyme activity, protein-protein interactions, subcellular localization, signal transduction pathways, and protein degradation. Aberrant PTM patterns contribute to numerous diseases including cancer, neurodegenerative disorders, metabolic syndromes, and immune dysfunctions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Post-Translational Modification (PTM).